Accessibility Toolbar

Bascom Palmer Eye Institute

News »

News 2011

{alt}

Avastin, Lucentis proven equally effective - Bascom Palmer ophthalmologist advocates global reform

April 28, 2011

A federal funded study finds that Avastin, a drug approved to treat some cancers and that is commonly used off-label to treat age-related macular degeneration (AMD), is as effective as the Food and Drug Administration-approved drug, Lucentis, for the treatment of AMD. The results are being reported following the first year of a two-year, multi-center study involving 1,185 patients treated at 43 clinical centers in the United States. The report, from the Comparison of AMD Treatments Trials (CATT), was published online in the New England Journal of Medicine today, April 28, 2011 and will be in the May 12 print edition.

{alt}

Bascom Palmer Eye Institute's Vision Van Takes Flight

April 12, 2011

On April 12, the Bascom Palmer Eye Institute Vision Van left Miami, Florida on its way to Sendai, Japan to join forces with Keio University School of Medicine, Iwate University School of Medicine, Tohoku University School of Medicine and the Japanese Ophthalmological Society in a special Japan Eye Rescue Mission to assist Japan with recovery from the devastation caused by the Tohoku-Pacific Ocean Earthquake.